Ann Cunningham
Direktor/Vorstandsmitglied bei VISTAGEN THERAPEUTICS, INC.
Vermögen: - $ am 31.05.2024
Aktive Positionen von Ann Cunningham
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
VISTAGEN THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 10.01.2019 | - |
Independent Dir/Board Member | 10.01.2019 | - | |
Corporate Officer/Principal | 01.05.2021 | 01.11.2022 |
Karriereverlauf von Ann Cunningham
Ehemalige bekannte Positionen von Ann Cunningham
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 01.01.2015 | 01.01.2018 |
ELI LILLY AND COMPANY | Corporate Officer/Principal | 01.01.1999 | 01.01.2013 |
Otsuka America Pharmaceutical, Inc.
Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America Pharmaceutical, Inc. manufactures and supplies pharmaceutical products. It develops drugs for neuroscience, cardiovascular, and gastrointestinal treatments. The company was founded in 1989 and is headquartered in Rockville, MD. | Corporate Officer/Principal | - | - |
I3 Strategy Partners LLC | Gründer | - | - |
Corporate Officer/Principal | - | - |
Ausbildung von Ann Cunningham
Yale University | Undergraduate Degree |
Stephen M. Ross School of Business | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 7 |
Israel | 2 |
Operativ
Corporate Officer/Principal | 5 |
Director/Board Member | 1 |
Independent Dir/Board Member | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
ELI LILLY AND COMPANY | Health Technology |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
VISTAGEN THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Otsuka America Pharmaceutical, Inc.
Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America Pharmaceutical, Inc. manufactures and supplies pharmaceutical products. It develops drugs for neuroscience, cardiovascular, and gastrointestinal treatments. The company was founded in 1989 and is headquartered in Rockville, MD. | Health Technology |
I3 Strategy Partners LLC |
- Börse
- Insiders
- Ann Cunningham
- Erfahrung